Kappa Bioscience
K2 goes global
Our Material:
- K2VITAL® ExperienceCard concept products, available for license‑free launch.
- 4th Edition Formulation LookBook
- Vitamin K2 Stability/Label claim 2017 Report
Free of charge Label Claim Testing
Shelf stability is vital to successful K2 products –ensuring quality to customers and brands.
Do your K2 MK-7 products meet label claim?
Are they pure, all-trans bioactive MK-7?
Ingredients
The Kappa portfolio of premium ingredients represents a team of Superheroes for the bone and heart dietary supplements health categories.
Experience K2
K2 Academy
Kappa deeply believes in the promise of vitamin K2 MK-7 and has a mission to improve health and well-being globally. Kappa developed the K2 Academy as a learning center on all facets of vitamin K2, from history to health, manufacturing to final formulation. The Academy includes a range of tools in a variety of formats educate new distributors, customers and the public on the promise of K2VITAL®.
K2 Introduction
The History of K2
The Different Vitamins in the K Family
All-trans Means All-bioactive
K2 Deficiency
Commercial Market Development
Bone Health
Pregnancy
Children
Heart Health
Bioequivalence – Natural vs. Synthetic K2
K2 Stability
Kappa Chemistry Custom Synthesis
Analytical Materials and Methods
Daily Dosage & Overage
About Us
The origin of K2VITAL® dates back to 2006, when Norwegian researcher, Dr Inger Reidun Aukrust, together with her team, discovered a process to produce all-trans Vitamin K2, MK-7, using natural compounds such as geraniol and farnesol in a strictly controlled synthesis process. The significance of the process for all-trans vitamin K2 MK-7 has been recognised and patented. For vitamin K’s, two stereo chemical versions can exist: cis and trans forms of the molecule. The cis form remains biologically inactive, while the trans form has a full biological potential.
